Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 10,500 · FY2023 8,500 · FY2024 0 — 3-yr total 19,000
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company buys and sells pharmaceutical medications.
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 23,510 | 26,049 | 30,562 | 31,602 | 33,640 | 37,829 | 44,821 | 46,251 | +10.1% |
| Total COGS | 13,594 | 15,800 | 16,350 | 18,113 | 18,805 | 20,367 | 23,078 | 29,418 | +11.7% |
| Gross Profit | 9,916 | 10,249 | 14,212 | 13,489 | 14,836 | 17,462 | 21,743 | 16,833 | +7.9% |
| Gross Margin | 42.2% | 39.3% | 46.5% | 42.7% | 44.1% | 46.2% | 48.5% | 36.4% | |
| 1,364 | 4,405 | 5,992 | 5,565 | 5,988 | 7,684 | 9,274 | 13,152 | +38.2% | |
| EBITDA | 8,552 | 5,844 | 8,220 | 7,924 | 8,848 | 9,778 | 12,469 | 3,681 | -11.3% |
| EBITDA Margin | 36.4% | 22.4% | 26.9% | 25.1% | 26.3% | 25.8% | 27.8% | 8.0% | |
| Total D&A | 268 | 259 | 264 | 299 | 302 | 342 | 283 | 295 | +1.4% |
| EBIT / Operating Income | 8,283 | 5,584 | 7,955 | 7,626 | 8,545 | 9,437 | 12,185 | 3,386 | -12.0% |
| Total Interest Expense | 0 | 314 | 212 | 262 | 207 | 169 | 88 | 131 | -13.6% |
| 343 | 448 | 36 | 1,581 | 2,290 | 2,137 | 3,854 | 6,026 | nmf | |
| Profit Before Tax | 7,940 | 5,719 | 7,707 | 8,944 | 10,628 | 11,405 | 15,951 | 9,281 | +2.3% |
| Total Income Tax | 15 | 0 | 0 | 1,106 | 1,015 | 1,332 | 1,419 | 416 | +61.4% |
| Net Profit / (Loss) | 4,535 | 5,719 | 7,707 | 7,838 | 9,613 | 10,072 | 14,532 | 8,866 | +10.0% |
| Net Margin | 19.3% | 22.0% | 25.2% | 24.8% | 28.6% | 26.6% | 32.4% | 19.2% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →